BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16698411)

  • 1. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.
    Michel CE; Solomon AW; Magbanua JP; Massae PA; Huang L; Mosha J; West SK; Nadala EC; Bailey R; Wisniewski C; Mabey DC; Lee HH
    Lancet; 2006 May; 367(9522):1585-90. PubMed ID: 16698411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis.
    Zambrano AI; Muñoz BE; Mkocha H; Dize L; Gaydos CA; Quinn T; West SK
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):997-1000. PubMed ID: 28535271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district.
    Odonkor M; Naufal F; Munoz B; Mkocha H; Kasubi M; Wolle M; West S
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009343. PubMed ID: 33861754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.
    Lee JS; Muñoz BE; Mkocha H; Gaydos CA; Quinn TC; West SK
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2761. PubMed ID: 24722392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme.
    Mkocha H; Munoz B; West S
    Tanzan J Health Res; 2009 Jul; 11(3):103-10. PubMed ID: 20734706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serology for trachoma surveillance after cessation of mass drug administration.
    Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal.
    Harding-Esch EM; Kadimpeul J; Sarr B; Sane A; Badji S; Laye M; Sillah A; Burr SE; MacLeod D; Last AR; Holland MJ; Mabey DC; Bailey RL
    BMC Public Health; 2017 Jul; 18(1):62. PubMed ID: 28747198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma.
    Ngondi J; Gebre T; Shargie EB; Adamu L; Ejigsemahu Y; Teferi T; Zerihun M; Ayele B; Cevallos V; King J; Emerson PM
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1001-10. PubMed ID: 19178920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children.
    Pickering H; Ramadhani AM; Massae P; Mafuru E; Malisa A; Mbuya K; Makupa W; Mtuy T; Derrick T; Houghton J; Bailey RL; Mabey DCW; Burton MJ; Holland MJ
    Front Public Health; 2022; 10():1015714. PubMed ID: 36324475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can corneal pannus with trachomatous inflammation--follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?
    Derrick T; Holland MJ; Cassama E; Markham-David R; Nabicassa M; Marks M; Bailey RL; Last AR
    Parasit Vectors; 2016 Jan; 9():30. PubMed ID: 26812948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trachoma: an overview.
    Burton MJ
    Br Med Bull; 2007; 84():99-116. PubMed ID: 18175788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania.
    Wolle MA; Muñoz BE; Mkocha H; West SK
    Ophthalmology; 2009 Feb; 116(2):243-7. PubMed ID: 19091415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trachoma and antibiotic use: the 'A' in SAFE.
    West S
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):75-83. PubMed ID: 22149616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for control of trachoma: observational study with quantitative PCR.
    Solomon AW; Holland MJ; Burton MJ; West SK; Alexander ND; Aguirre A; Massae PA; Mkocha H; Muñoz B; Johnson GJ; Peeling RW; Bailey RL; Foster A; Mabey DC
    Lancet; 2003 Jul; 362(9379):198-204. PubMed ID: 12885481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of clinical trachoma and infection in Aboriginal communities.
    Michel CE; Roper KG; Divena MA; Lee HH; Taylor HR
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e986. PubMed ID: 21423648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
    Ervin AM; Mkocha H; Munoz B; Dreger K; Dize L; Gaydos C; Quinn TC; West SK
    Ophthalmic Epidemiol; 2016 Dec; 23(6):347-353. PubMed ID: 27820670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
    West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
    Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.
    Cama A; Müller A; Taoaba R; Butcher RMR; Itibita I; Migchelsen SJ; Kiauea T; Pickering H; Willis R; Roberts CH; Bakhtiari A; Le Mesurier RT; Alexander NDE; Martin DL; Tekeraoi R; Solomon AW;
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005863. PubMed ID: 28898240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.